Recently, the usefulness of serum uromodulin (sUmod) as a novel renal biomarker has been attracting attention. Clinical evidence regarding sUmod measurements has been accumulated by analyzing cross-sectional data. However, little is known about the longitudinal data on sUmod. Therefore, we decided to investigate the variability of sUmod in patients with acute kidney injury due to different causes. High concentrations of sUmod have been observed in patients with acute tubular injury (ATI) and/or acute interstitial nephritis (AIN). sUmod could be used as an auxiliary diagnostic tool for ATI and AIN.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743145 | PMC |
| http://dx.doi.org/10.1159/000523855 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Uromodulin and Risk of Upper Urinary Tract Infections: A Mendelian Randomization Study.
Am J Kidney Dis
January 2025
Yale Department of Chronic Disease Epidemiology and Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health, New Haven, CT, USA; Mid-Norway Center for Sepsis Research, Department of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Rationale & Objective: Observational studies suggest that uromodulin, produced by the kidneys, is associated with a reduced the risk of upper urinary tract infections, but inferences are limited by potential confounding factors. This study sought to explore further the validity of this association using Mendelian randomization.
Study Design: Two-sample Mendelian randomization study.
Serum and urinary uromodulin concentration in children and young adults with chronic kidney disease.
Pediatr Nephrol
January 2025
Department of Paediatrics, University Medical Centre Maribor, Ljubljanska ulica 5, 2000, Maribor, Slovenia.
Background: Serum and urinary uromodulin are emerging as potential cardiovascular risk factors. The aim of our study was to determine uromodulin in both serum and urine to evaluate their potential as early cardiovascular risk markers and markers of kidney function in children and young adults.
Methods: This case-control study included 72 participants - 42 children and young adults with chronic kidney disease stages 1-2 and 30 healthy controls.
The natural immune molecules urinary Tamm-Horsfall protein and pentraxin 3 as predictors for recurrent urinary tract infection severity: a single-center self-control study.
Ren Fail
December 2025
Department of Nephrology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Objective: The innate immune defense plays a pivotal role in protecting the urinary tract from uropathogenic invasion and maintaining immune homeostasis. Dysregulation of the innate immune system can result in recurrent urinary tract infections (RUTI) due to heightened susceptibility to uropathogens. Despite this, predicting the risk of recurrence and the degree of immune compromise in patients who have had one urinary tract infection remains challenging.
View Article and Find Full Text PDFGenotype and Determinants of Urinary Uromodulin in African Populations.
Kidney Int Rep
December 2024
Institute of Physiology, University of Zurich, Zurich, Switzerland.
Article Synopsis
- SNPs linked to chronic kidney disease (CKD) show different impacts on urinary uromodulin levels in Black and White populations, with unknown factors in African groups.
- Clinical studies involving young and middle-aged adults reveal that Black individuals have lower uromodulin levels and higher prevalence of CKD-risk SNPs compared to Whites.
- Findings highlight significant ethnic variations in genetic and clinical factors affecting uromodulin, suggesting the need for tailored approaches in kidney function research and medicine.
Kidney disease in multiple myeloma.
Presse Med
December 2024
Division of Pathology, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, Canada.
Article Synopsis
- * Quick diagnosis and treatment of kidney problems in these patients are crucial, with therapies focusing on hydration, correcting contributing factors, and administering effective anti-myeloma drugs while considering the patient's kidney function and overall health.
- * Advanced treatments like plasma exchange may improve kidney recovery in severe cases, and newer combinations of medications show promise, with the possibility of kidney transplantation for some patients in the future.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!